"Purpura" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS).
| Descriptor ID |
D011693
|
| MeSH Number(s) |
C15.378.100.802 C23.550.414.950 C23.888.885.687
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Purpura".
Below are MeSH descriptors whose meaning is more specific than "Purpura".
This graph shows the total number of publications written about "Purpura" by people in this website by year, and whether "Purpura" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 3 | 2 | 5 |
| 2018 | 1 | 6 | 7 |
| 2020 | 11 | 5 | 16 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Purpura" by people in Profiles.
-
Flagellate purpura associated with COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2022 Jan; 36(1):e33-e34.
-
Papulo-purpuric dermatitis of childhood: a distinct PLEVA-like eruption associated to SARS-CoV-2 infection. Clinical, histopathological and immunohistochemical study of 10 cases. Pediatr Dermatol. 2021 Sep; 38(5):1185-1190.
-
A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J Cutan Pathol. 2022 Jan; 49(1):17-28.
-
Retiform purpura and extensive skin necrosis as the single manifestation of SARS-CoV-2 infection. J Eur Acad Dermatol Venereol. 2021 Dec; 35(12):e839-e841.
-
Asymmetrical cutaneous vasculitis following COVID-19 vaccination with unusual eosinophil preponderance. Clin Exp Dermatol. 2021 Dec; 46(8):1596-1597.
-
Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e719-e721.
-
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. Isr Med Assoc J. 2021 Jun; 23(6):341.
-
Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course. J Cutan Pathol. 2021 Sep; 48(9):1166-1172.
-
Leucocytoclastic vasculitis secondary to COVID-19 infection in a young child. BMJ Case Rep. 2021 Apr 07; 14(4).
-
Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic. Cutis. 2021 Apr; 107(4):209-215.